Athenex has been focused on protecting inventions in United States(US) with three publications in Q2 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 100% filings and 100% grants. The United States(US) patent Office are among the top ten patent offices where Athenex is filings its patents. Among the top granted patent authorities, Athenex has 100% of its grants in United States(US).

Roche and Johnson & Johnson could be the strongest competitors for Athenex

Patents related to climate change and rare diseases lead Athenex's portfolio

Athenex has the highest number of patents in climate change followed by, rare diseases. For climate change no patents were filed and 67% of patents were granted in Q2 2024.

Stem cell transplantation related patents lead Athenex portfolio followed by viral infections, and hepacivirus infections

Athenex has highest number of patents in stem cell transplantation followed by viral infections, hepacivirus infections, hepatitis b, and kaposi sarcoma.

For comprehensive analysis of Athenex's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.